Company profile
3M CO
NYSE:MMMMedical/Dental Instruments
Drug pipeline (17)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| CIRCANOL | approved | — | 0 | — |
| DISIPAL | approved | — | 0 | — |
| DUO-MEDIHALER | approved | — | 0 | — |
| ISOPROTERENOL HYDROCHLORIDE | approved | — | 0 | — |
| LIPO-HEPIN | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02203591 | phase3 | completed | 2014-07-01 | 2015-03-01 | 3M | In Vivo Efficacy Study of Patient Preoperative Preps |
FDA applications (20)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| ANDA 086363 | 1987-07-16 | ANDA | 3M PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 088364 | 1987-07-16 | ANDA | 3M PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 088369 | 1987-07-16 | ANDA | 3M PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 089132 | 1987-07-16 | ANDA | 3M PHARMACEUTICALS INC | |||||
Loading… | ||||||||
| ANDA 084868 | — | ANDA | 3M PHARMACEUTICALS INC | |||||
Loading… | ||||||||